Highlights Cizzle Biotechnology Holdings Plc

Stocks

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 05:49:09 15/07/2026 pm IST			5-day change	1st Jan Change
1.990 ^GBX	-7.44%		-20.40%	+28.39%

03:37pm	WINNERS & LOSERS: Angus Energy revenue up; Iofina production jumps	AN
13/07	WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump	AN

Highlights

16/06	Cizzle Biotechnology Secures Clinical Approval for Lung Cancer Test in US	MT
16/06	Cizzle Biotechnology Holdings Plc CIZ1B Biomarker Test Approval For Clinical Use In USA	CI
12/06	U.S. Patent and Trademark Office Allows Patent Application Covering its Core Methods to Measure CIZ1B Lung Cancer Biomarker	CI
12/06	Cizzle Biotechnology Receives US Patent for Lung Cancer Biomarker Test	MT
30/04	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
24/02	Cizzle Biotechnology Holdings plc Provides an Update on Progress Towards the Accreditation and Launch of Its Proprietary Test for the Ciz1b Biomarker Test	CI
04/02	Cizzle Biotechnology Lung Cancer Test Secures Patent in Canada	MT
04/02	Cizzle Biotechnology Holdings plc Announces Patent Applications That Claim Protection for Methods That Measure the Ciz1b Lung Cancer Biomarker	CI
30/25/30	Cizzle Biotechnology Announces Update on Clinical Laboratory Partnerships in Usa	CI
30/25/30	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/25/18	Cizzle Biotechnology Advances US Expansion via Commercialization Deal	MT
18/25/18	Cizzle Biotechnology Holdings plc Announces Commercial Progress in USD Advance Royalty Schedule Revised for Early Payment	CI
30/25/30	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/25/28	Cizzle Biotechnology Licensing Partner Signs Contract for CIZ1B Lung Cancer Test in Caribbean	MT
28/25/28	Cizzle Biotechnology Holdings plc Announces That Its Licensing Partner Cizzle Bio Inc. Has Executed Its First Contract in the Caribbean	CI
24/25/24	Cizzle Biotechnology Partner Appoints Lab for US Launch of Lung Cancer Test	MT
02/25/02	Cizzle Biotechnology Holdings plc Provides Update on Launch of CIZ1B Biomarker Assay	CI
16/24/16	Cizzle Biotechnology Expands Exclusive Lung Cancer Test Licensing Deal to Caribbean	MT
16/24/16	Cizzle Biotechnology Holdings Plc Announces an Extension to Its Exclusive Licensing and Partnership Agreement with Cizzle Bio Inc	CI
21/24/21	Cizzle Biotechnology Signs Exclusive Licensing Deal for Lung Cancer Test in US	MT
21/24/21	Cizzle Biotechnology Holdings plc Announces North American Licensing Deal to Launch Revolutionary Early Lung Cancer Blood Test in 2025	CI
03/24/03	Cizzle Biotechnology Holdings plc Updated on Licensing and Partnership Agreement	CI
30/24/30	Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/24/09	Cizzle Biotechnology Agrees Lung Cancer Screening Collaboration With US Hospital	MT
09/24/09	Cizzle Biotechnology Holdings plc Announces Collaboration with Moffitt Cancer Center	CI